Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$7.23M Buy
134,014
+2,027
+2% +$110K 0.01% 1702
2014
Q2
$7.06M Sell
131,987
-705
-0.5% -$36.3K 0.01% 1641
2014
Q1
$6.34M Buy
132,692
+8,737
+7% +$409K 0.01% 1634
2013
Q4
$5.96M Buy
123,955
+11,749
+10% +$537K 0.01% 1701
2013
Q3
$4.82M Buy
112,206
+13,757
+14% +$598K ﹤0.01% 1744
2013
Q2
$4.22M Buy
+98,449
New +$4.24M 0.01% 1800

Other funds holding STE

UBS's STE Position: Q3 2014 in Review

UBS increased its Steris (STE) stake by 1.5% in Q3 2014, buying an estimated $110K and bringing the position to 134,014 shares worth $7.23M. The position accounts for 0.01% of the portfolio, ranked #1702.

UBS first reported a position in STE in Q2 2013 and has held it in 6 quarters since. 240 funds tracked by Wall St. Rank hold STE as of Q3 2014.

  • UBS held 134,014 shares of Steris worth $7.23M as of Q3 2014.
  • UBS bought 2,027 Steris shares in Q3 2014, an estimated $110K.
  • Steris made up 0.01% of UBS's portfolio in Q3 2014, its #1702 holding.
  • UBS first reported a position in Steris in Q2 2013 and has held it in 6 quarters since.
  • 240 funds tracked by Wall St. Rank held Steris as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.